HopeStage
Back to overview

Depression studies

Topics
More filters

Depression

Depression involves persistent low mood or loss of interest, often with tiredness and changes in sleep or appetite.

7264studies shown
Showing 1,645-1,656 of 7,264
Drug study icon
CompletedNCT05870540

BPL-003 Efficacy and Safety for treatment-resistant depression

What is this study about?

This study evaluated the safety and effectiveness of BPL-003 for people with depression.

This study has finished and is no longer accepting participants.

Multiple locations, including Birmingham
DepressionMedication studyAges 18–75
Countries
United States, Australia, United Kingdom, + 3 others
Sponsor
Beckley Psytech Limited
Device study icon
Active Not RecruitingNCT00565617

Epidural Cortical Stimulation for Depression

Official study title

A Pilot Safety and Efficacy Study of Epidural Prefrontal Cortical Stimulation (EpCS) in Severe Treatment Resistant Depression

This study is no longer accepting new participants.

In Charleston
DepressionDevice studyAges 21–80
Countries
United States
Sponsor
Medical University of South Carolina
Device study icon
CompletedNCT06166082

Intensive Accelerated iTBS for the Treatment-Resistant Depression

Official study title

Intensive Accelerated Intermittent Theta Burst Stimulation in Treatment-resistant Depression: A Multicenter, Randomized, Double-blind, Placebo Parallel Controlled Trial

This study has finished and is no longer accepting participants.

Multiple locations, including Baoding
DepressionDevice studyAges 22–65
Countries
China
Sponsor
Changping Laboratory
Drug study icon
CompletedNCT06138691

KET-RO Plus RO DBT for Treatment Resistant Depression

Official study title

Medication-assisted Psychotherapy: Using Ketamine-enhanced Radically Open Dialectical Behavior Therapy (RO DBT) to Target Neural and Behavioral Mechanisms of Action in Adults With Moderate to Severe Depression

This study has finished and is no longer accepting participants.

In St Louis
DepressionInterventional studyAges 18–65
Countries
United States
Sponsor
Washington University School of Medicine
Device study icon
CompletedNCT03428828

Neurofeedback for Treatment Resistant Depression

Official study title

Amygdala rtfMRI Neurofeedback for Treatment Resistant Depression

This study has finished and is no longer accepting participants.

In Pittsburgh
DepressionDevice studyAges 18–55
Countries
United States
Sponsor
Kymberly Young
Device study icon
SuspendedNCT05842291

pBFS Guided High-dose rTMS Therapy for Treatment-Resistant Depression

Official study title

Personalized Brain Functional Sectors (pBFS) Guided High-dose rTMS Therapy for Treatment-resistant Depression: A Randomized, Double-Blind, Sham-controlled Trial

Recruitment is currently suspended.

In Beijing
DepressionDevice studyAges 18–65
Countries
China
Sponsor
Changping Laboratory

Registry coverage

We gather information about mental health clinical trials from the public registries we index. Coverage is still expanding, so some studies may not appear yet.